Skip Navigation


European Heart Journal Advance Access originally published online on March 24, 2009
European Heart Journal 2009 30(8):887-889; doi:10.1093/eurheartj/ehp117
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
30/8/887    most recent
ehp117v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gershlick, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gershlick, A. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org

Managing myocardial infarction in the elderly: time to bury inappropriate concerns instead

Anthony H. Gershlick*

Divison of Cardiology, Clinical Sciences Wing, Glenfield Hospital, Leicester LE3 9QP, UK

* Corresponding author. Tel: +44 116 2563045, Fax: +44 116 2875792, E-mail: agershlick@aol.com

This editorial refers to ‘Changes in management of elderly patients with myocardial infarction’{dagger}, by F. Schiele et al., on page 987

The first 150 words of the full text of this article appear below.

‘Age is not a particularly interesting subject. Anyone can get old. All you have to do is live long enough’

Groucho Marx (1890–1977)

‘Of all the self-fulfilling prophecies in our culture, the assumption that aging means decline and poor health is probably the deadliest’.

Marilyn Ferguson, The Aquarian Conspiracy, 1980

An ageing population, the prevelance of cardiovascular disease as a major cause of morbidity and mortality, and the development of potent therapies with potential life-threatening side effects present challengies for patient care that are increasingly likely to require serious consideration in coming years. In general, cardiovascular mortality and morbidity have fallen as therapeutic advances have been implemented, especially in the management of acute coronary syndromes (ACS)—here potent anti-platelet/anti-thrombotic agents have improved non-ST-elevation myocardial infarction (NSTEMI) outcomes, and in ST-elevation myocardial infarction (STEMI) management, the use of thrombolytic plus adjunctive pharmacotherapy and the uptake of primary percutaneous coronary angioplasty (P-PCI), also . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study
Sanjit S. Jolly, Janice Pogue, Kimberly Haladyn, Ron J.G. Peters, Keith A.A. Fox, Alvaro Avezum, Bernard J. Gersh, Hans Jurgen Rupprecht, Salim Yusuf, and Shamir R. Mehta
EHJ 2009 30: 900-907. [Abstract] [Full Text]  

Changes in management of elderly patients with myocardial infarction
François Schiele, Nicolas Meneveau, Marie France Seronde, Vincent Descotes-Genon, Joanna Oettinger, Fiona Ecarnot, Jean-Pierre Bassand, and on behalf of the ‘Reseau de Cardiologie de Franche Comte’
EHJ 2009 30: 987-994. [Abstract] [Full Text]